Dr. Michael Chen is the CEO & Co-founder of Great Bay Bio. He has more than 30 years of experience in technologies, operation management, and business partnership in the biopharmaceutical industry. Prior to Great Bay Bio, Dr. Chen served as the senior positions in Synageva, Faville, and Applied Biotech. In the last five years Dr. Chen has led the GBB team to successfully launch several AI-enabled bioprocessing platforms. Dr. Chen holds a Ph.D. degree in biochemistry from the University of Georgia and a postdoctoral position from The Scripps Research Institute in San Diego. He has received several NIH postdoctoral scholarships and has published 14 SCI papers, and owns more than 50 patents.